Individuals respond differently to administration of drugs, exposures to xenobiotics, and in
general to many other epidimiological and environmental factors. In the postgenomic era
understanding is coming that to a major extent individual succeptibility and resistance are
genetically predetermined. They are associated with polymorphic variations in genes, microDNA, and
other functionally important regions of the genome. How these pieces co-express together making-up
each individual phenotype, perhaps, is the next greatest puzzle after the genomic text itself.
P O L Y M A R K
is a web-service that models a population distribution of health effects outcomes that are associated
with polymophic variations in multiple genes. It combines together in one joint distribution idiosyncratic
gene / health-effect associations expressed by Odds Ratios (ORs), and estimates the probability of each
possible genotypic combination from the observed idiosyncratic (marginal) gene frequencies. Next, a
distribution of cumulative risk attributed to polygenic variations is determined. When citing POLYMARK
in the literature, the following citation should be used:
Demchuk, E., Yucesoy, B., Johnson, V.J., Weston, A., Germolec, D.R.,
De Rosa, C.T. & Luster, M.I. (2007) A statistical model to assess genetic
susceptibility as a risk factor in multifactorial diseases: Lessons from occupational asthma --
Environ. Health Persp. 115(2), 231-234.
The form accepts idiosyncraitic gene data. Generally, the more genes the better, however, it takes noticable amount of time to
calculate more than 20 genes/biomarkers. During that time your browser may or may not time out. Check out the current version
limits below. The input shall be tabulated in three columns, one marker per row. The 1st column is an
odds ratio reported in epidimiological or clinical trials, the 2nd is the frequency of genetic biomarker associated with the health effects
in controls, and the 3rd is the frequency of biomarker in cases. Follow the example below, or you may copy it to the form to test:
| 2.46 | 0.117021276596 | 0.245551601423 |
| 2.24 | 0.033707865169 | 0.072386058981 |
| 1.50 | 0.223443223443 | 0.302127659574 |
| 2.70 | 0.089201877934 | 0.209302325581 |
| 7.76 | 0.018691588785 | 0.128712871287 |
| 3.14 | 0.098360655738 | 0.255319148936 |
| 1.83 | 0.108651911469 | 0.182352941176 |
| 0.28 | 0.289473684211 | 0.101694915254 |
| 2.23 | 0.218649517685 | 0.384615384615 |
| 8.18 | 0.017543859649 | 0.127516778523 |
| 4.47 | 0.160000000000 | 0.460000000000 |
where the columns are
| < Odds Ratio > |
< frequency in CONTROLS > |
< frequency in CASES > |
At present the online version depends on the following approximations and limitations:
- genes/biomarkers are mutualy independent
- not more than 23 genes/biomarkers can be processed at once
________
This web site is provided as a service to its visitors and the web site information
is provided on an "AS IS" basis without warranties, express or implied, for informational purposes only,
not intended for trading purposes or advice. Use of such information is at your own risk. Neither the author
nor its parent institutions are liable for any informational errors, incompleteness, or delays, or for any
actions taken in reliance on information contained herein. By accessing this site, you agree not to redistribute
the information without appropriately acknowledging the source.
Saturday, 26-May-2007